Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru

C. G. Duarte, C. Bonilla, G. Guimarães, R. A. Machado De Avila, T. M. Mendes, W. Silva, B. Tintaya, A. Yarleque, C. Chávez-Olórtegui

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

© 2014 Elsevier Ltd. All rights reserved. In this work, an anti-loxoscelic serum was produced by immunizing horses with a recombinant dermonecrotic protein from Loxosceles intermedia (rLiD1). Anti-rLiD1 antibodies were able to recognize different species of Loxosceles venoms by Western Blot and ELISA. The efficacy of anti-rLiD1 serum against the toxic effects of Loxosceles laeta (Peru) venom was tested, showing that anti-rLiD1 serum can neutralize those effects. This study confirms that recombinant proteins can be good candidates to replace crude venoms for antivenom production.
Original languageAmerican English
Pages (from-to)37-40
Number of pages4
JournalToxicon
DOIs
StatePublished - 1 Jan 2015

Fingerprint Dive into the research topics of 'Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru'. Together they form a unique fingerprint.

  • Cite this